fingolimod hydrochloride has been researched along with T-Lymphocytopenia, Idiopathic CD4-Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuzawa, M; Hagiwara, N; Ikeda, T; Inoue, M; Koshinaga, T; Sugito, K | 1 |
1 other study(ies) available for fingolimod hydrochloride and T-Lymphocytopenia, Idiopathic CD4-Positive
| Article | Year |
|---|---|
The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
Topics: Animals; Fingolimod Hydrochloride; Graft Survival; Immunosuppressive Agents; Lymphatic Diseases; Lymphocyte Count; Lymphocytes; Lymphoid Tissue; Lymphopenia; Male; Mice; Propylene Glycols; Skin Transplantation; Sphingosine; Splenectomy; T-Lymphocytopenia, Idiopathic CD4-Positive | 2005 |